Operational status for active transdermal medicament patch
First Claim
1. A transdermal medicament patch comprising:
- (a) a flexible, planar biocompatible substrate having on one side thereof a therapeutic face configured for releasable retention against the skin of a patient;
(b) a planar medicament matrix secured to said therapeutic face of said substrate interior the periphery thereof, said medicament matrix being susceptible to permeation by medicament, and said medicament matrix effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon;
(c) a return electrode on the same side of said substrate as said medicament matrix interior said periphery of said therapeutic face, said return electrode effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon;
(c) a power source carried on said substrate and being so electrically coupled between said medicament matrix and said return electrode as to cause iontophoretic migration of medicament from said medicament matrix into the skin of the patient; and
(d) dosage control means carried non-removably on said substrate for limiting to a predetermined medicament quantity the total medicament migrated iontophoretically from said medicament matrix into the skin of the patient during a plurality of temporally non-contiguous therapy subsessions.
1 Assignment
0 Petitions
Accused Products
Abstract
An active transdermal medicament patch includes a planar substrate with a therapeutic face releasably retainable against the skin of a patient. A return electrode and a medicament matrix susceptible to permeation by medicament are secured at separated locations on the therapeutic face and electrically conductively engage the skin. A detector monitors iontophoretic medicament migration into the skin. An integrator operating on the output of the detector produces a running cumulative total of the amount of medicament delivered during a plurality of temporally non-contiguous therapy subsessions. A circuit breaker terminates medicament migration, when the output of the integrator equals a predetermined medicament quantity. A timer active during medicament migration stimulates a driver to operate a light-emitting diode in a distinct delivery confirmation mode during each a sequence of non-overlapping predetermined therapy subsessions, respectively. A circuit board on the substrate in a compact, folded state bears interconnected electrical circuit components.
-
Citations
38 Claims
-
1. A transdermal medicament patch comprising:
-
(a) a flexible, planar biocompatible substrate having on one side thereof a therapeutic face configured for releasable retention against the skin of a patient; (b) a planar medicament matrix secured to said therapeutic face of said substrate interior the periphery thereof, said medicament matrix being susceptible to permeation by medicament, and said medicament matrix effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon; (c) a return electrode on the same side of said substrate as said medicament matrix interior said periphery of said therapeutic face, said return electrode effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon; (c) a power source carried on said substrate and being so electrically coupled between said medicament matrix and said return electrode as to cause iontophoretic migration of medicament from said medicament matrix into the skin of the patient; and (d) dosage control means carried non-removably on said substrate for limiting to a predetermined medicament quantity the total medicament migrated iontophoretically from said medicament matrix into the skin of the patient during a plurality of temporally non-contiguous therapy subsessions. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
-
12. A transdermal medicament patch comprising:
-
(a) a flexible, planar biocompatible substrate having on one side thereof a therapeutic face configured for releasable retention against the skin of a patient; (b) a medicament matrix secured to said therapeutic face of said substrate interior the periphery thereof, said medicament matrix effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon; (c) a return electrode on the same side of said substrate as said medicament matrix interior said periphery of said therapeutic face, said return electrode effecting electrically conductive engagement with the skin of the patient when said substrate is retained thereupon; (d) a power source carried on said substrate and electrically coupled between said medicament matrix and said return electrode; and (d) therapy status advisement means non-removably carried on said substrate and driven by said power source for communicating to a user the extent of completion of a predetermined therapy period wherein medicament is to be iontophoretically delivered from said medicament matrix into the skin of the patient. - View Dependent Claims (13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)
-
-
24. A transdermal medicament patch comprising:
-
(a) a flexible, planar biocompatible substrate having on one side thereof an upper face and on the other side thereof a therapeutic face configured for releasable retention against the skin of a patient; (b) a circuit board carried on said upper face of said substrate, said circuit board having on one side thereof a support face and on the other side thereof an attachment face, a portion of said attachment face of said circuit board being non-removably secured to said upper face of said circuit board; (c) a printed circuit on said support face of said circuit board; (d) a power source carried on said support face of said circuit board; (e) an electrode carried on said support face of said circuit board, said electrode being electrically coupled to said power source by said printed circuit; and (f) electrode flexion means traversing said circuit board intermediate said electrode and said power source for permitting bending of said circuit board between; (i) a planar state of said circuit board; and (ii) a compact state of said circuit board, in said compact state of said circuit board a portion of said attachment face in an electrode region of said circuit board located on the same side of said electrode flexion means as said electrode engages a portion of said attachment face in a power source region of said circuit board located on the same side of said electrode flexion means as said power source - View Dependent Claims (25, 26, 27, 28, 29, 30, 31, 32, 33)
-
-
34. A transdermal medicament patch comprising:
-
(a) a flexible, planar biocompatible substrate having on one side thereof an upper face and on the other side thereof a therapeutic face configured for releasable retention against the skin of a patient, said substrate having formed therethrough a first electrode aperture and a second electrode aperture separated therefrom; (b) a circuit board carried on said upper face of said substrate, said circuit board having on one side thereof a support face and on the other side thereof an attachment face configured in part for non-removable securement to said upper face of said circuit board, said circuit board being capable of assuming a planar state and a folded state, in said folded state of said circuit board portions of said attachment face in each of a first region and a nonadjacent second region of said circuit board engage corresponding portions of said attachment face in a third region of said circuit board intermediate said first and second regions; (c) a printed circuit on said support face of said circuit board; (d) an active electrode carried on said support face in said first region of said circuit board (e) a return electrode carried on said support face in said second region of said circuit board; (f) a power source carried on said support face of said circuit board, said power source being electrically coupled to said active electrode and to said return electrode by said printed circuit; and (g) an adhesive between said upper face of said substrate and a portion of said attachment face in said third region of said circuit board free of said first region of said circuit board and free of said second region of said circuit board in said folded state of said circuit board. - View Dependent Claims (35, 36, 37, 38)
-
Specification